MSB 3.21% $1.13 mesoblast limited

Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD, page-97

  1. 2,106 Posts.
    lightbulb Created with Sketch. 1187
    I rang the phone number at the bottom near Paul's name. Got out only words like "Hi, I'm looking at the announcement".... and then heard dial tone.

    I thought that's weird - I haven't said anything to warrant a hang up, maybe I've accidentally hung up myself with my cheek or something. So I dialed again and got an answering machine.

    I did leave a message saying I think there's a typo could they let me know.

    I don't know if the distinction between in vivo and in vitro in the announcement in the place it occurs would be considered important enough (by Silviu or Paul) to alter the announcement and so to run it through the ASX as an alteration bringing peoples attention to it when the distinction between in vivo and in vitro mostly would be blah and blahh to many readers who couldn't care less and amongst those like me that do - most of them will just assume its a typo.

    I do hope I get a courtesy phone call back though acknowledging the typo.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.